Supriya Lifescience Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Supriya Lifescience Ltd. on BSE

Search Inside the pdf :

Supriya Lifescience Ltd.

07 Aug 2025, 05:44PM

657.75

-0.60%

Investor Presentation

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that an earnings call will be held on Thursday, August 14, 2025 at 11.00 A.M. IST to discuss operational and financial performance of the Company for the quarter ended June 30, 2025. The invite giving requisite details including the pre-registration link and dial-in details is enclosed herewith. The investor presentation shall be shared with the Exchanges separately. Kindly take the information on record.

pdf

Supriya Lifescience Ltd.

06 Aug 2025

657.75

-0.60%

Board Meeting

Supriya Lifescience Ltd - 543434 - Board Meeting Intimation for Unaudited Financial Results For The Quarter …

BSE India

Supriya Lifescience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider and approve In terms of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this to inform you that a meeting of the Board of Directors of the Company will be held on Wednesday, August 13, 2025, inter alia to Consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2025. This is to further inform you that in accordance with the Company's Code of Conduct for Prevention of Insider Trading, the ''Trading Window' for dealing in the securities of the Company by Designated Persons and their immediate relatives is closed from July 1, 2025, till 48 hours after declaration of Unaudited Financial Results on August 13, 2025. Kindly take the above information on your records.

pdf

Supriya Lifescience Ltd.

23 Jul 2025

657.75

-0.60%

Company Update

Supriya Lifescience Ltd - 543434 - Clarification Regarding Shareholder Demat Requests

BSE India

Company has provided Clarification regarding Demat requests received erroneously from Shareholders of Supriya Pharmaceuticals Limited which is not related to Supriya Lifescience Limited.

pdf

Supriya Lifescience Ltd.

18 Jul 2025

657.75

-0.60%

Company Update

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Pursuant to relevant provisions of the SEBI (LODR) Regulations, 2015, we would like to inform you that the officials of our Company will be interacting with Analyst/Institutional Investors on Friday, July 25, 2025 as per the details mentioned in the attached communication. Kindly take the same on records.

pdf

Supriya Lifescience Ltd.

17 Jul 2025

657.75

-0.60%

Company Update

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Pursuant to relevant provisions of the SEBI (LODR) Regulations, 2015, we would like to inform you that the officials of our Company will be interacting with Analyst/ Institutional Investors on Thursday, July 24, 2025 as per the details mentioned in the attached communication. Kindly take the same on records.

pdf

Supriya Lifescience Ltd.

11 Jul 2025

657.75

-0.60%

Company Update

Supriya Lifescience Ltd - 543434 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Please find enclosed herewith duly signed certificate issued by MUFG Intime India Private Limited, our RTA, confirming compliance under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended June 30, 2025. Kindly take the same on record.

pdf

Supriya Lifescience Ltd.

01 Jul 2025

657.75

-0.60%

Company Update

Supriya Lifescience Ltd - 543434 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And …

BSE India

Disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015 for details of Show cause cum demand notice received from Office of the Commissioner of CGST & C.Ex, Mumbai.

pdf

Supriya Lifescience Ltd.

27 Jun 2025

657.75

-0.60%

SAST

Supriya Lifescience Ltd - 543434 - Closure of Trading Window

BSE India

Intimation for Closure of Trading Window

pdf

Supriya Lifescience Ltd.

17 Jun 2025

657.75

-0.60%

Company Update

Supriya Lifescience Ltd - 543434 - Email Communication To Shareholders Regarding Dividend Taxation Provisions

BSE India

Email communication to shareholders regarding taxation provisions.

pdf

Supriya Lifescience Ltd.

31 May 2025

657.75

-0.60%

Earnings Call

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Please find attached Earnings Call Transcript for the Earnings call held on May 28, 2025 with respect to Audited Financial Results of the Company for the quarter and year ended March 31, 2025.

pdf

VOTE: Is Supriya Lifescience Ltd. worth buying?

109 Votes:

Buy 86.24%

Sell 6.42%

Hold 7.34%